EVI1 in vivo analyses, especially in ovarian carcinoma, are contradictory: some find it to be associated with worse survival, while others detect an association with better survival, although EVI1 mRNA level was high in stage III/IV SOCs [35]. The gene discussed is MECOM; the disease is ovarian carcinoma.